Page 2 - The Smart Investor News

Choice reiterates 'Buy' on Jeena Sikho, sees 44% upside; stock rises 20%

Analysts Deepika Murarka and Stuti Bagadia expect JSLL to deliver revenue, Ebitda and PAT CAGR of 33.6 per cent, 34.9 per cent and 41.6 per cent, respectively, over FY26-FY29E

ITC slips 9% in 3 days; plunges 32% so far in 2026; should you buy or sell?

Volatility in cigarette volumes and EBIT to moderate from the initial transitionary phase; and given the MRP revisions are still underway, the outlook for cigarette biz remains uncertain, analysts.

IndusInd Bank falls 3% on insider trading, governance lapses allegations

The complaint adds to mounting scrutiny of IndusInd Bank ​after ​its March 2025 disclosure of a ₹2,000 crore derivatives accounting ​discrepancy.

Concord Biotech jumps 8% after USFDA approves Mycophenolate Mofetil ANDA

Concord Biotech received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL.

NHPC shares rise 5% as govt exercises greenshoe in OFS; retail window opens

The buying on the counter came after the Government of India, acting through the Ministry of Power, exercised the oversubscription option in the ongoing offer for sale (OFS)

Apar Industries rallies 6%, hits new high in weak market; here's why

Thus far in the calendar year 2026, Apar Industries has outperformed the market by surging 67 per cent, as compared to 13.4 per cent fall in the BSE Sensex.

NMDC shares rise 5% after Q4; Brokerages bullish but flag rich valuations

NMDC shares rose nearly 5 per cent on Tuesday after strong Q4 FY26 earnings. Brokerages remain positive on capacity expansion and diversification plans, though some caution on rich valuations.

ACME Solar rallies 9%, hits record high; up 70% from Jan low; here's why

ACME Solar launched a QIP, with reports indicating a fundraise of up to ₹2,500 crore to support growth capex, renewable energy project expansion and balance sheet strengthening.

NHPC slips 5% as govt OFS opens for non-retail investors at ₹71 floor price

According to the filing, the government has proposed to sell up to a 6 per cent stake in NHPC via an OFS on June 2-3 at a floor price of ₹71 per share

Mukul Agrawal, Vikas Khemani portfolio stock PTC Ind soars 20% in 2 days

PTC Industries rallied 5 per cent to ₹19,392 on the BSE in Tuesday's intra-day, and quoted close to its 52-week high of ₹19,439.95 touched on December 30, 2025.

Analysts split on Cyient after $218-mn TAO Digital acquisition; stock up 2%

While Emkay Global retained its 'Reduce' rating on Cyient, Choice Institutional Equities maintained a 'Buy' call, reflecting contrasting views on the strategic and financial implications of the deal

Gujarat Gas shares jump 6% after Q4 results; Motilal Oswal reiterates 'Buy'

Gujarat Gas shares jumped over 6% after Q4 FY26 results beat volume estimates. Motilal Oswal retained its 'Buy' rating and a target price of ₹490, citing strong Morbi demand recovery

Nifty FMCG index sheds 2%; Dabur slips 4%; ITC, Britannia hit 52-week lows

In the past one month, the FMCG index has underperformed the market, by falling 5 per cent, as against 2.3 per cent decline in Nifty 50.

Cummins India: Citi bets on data centre tailwinds; sees 14% upside

Post Q4 results, Citi Research has reiterated its 'Buy' rating on Cummins India and raised target price to ₹6,700 from ₹5,200. The target implies an upside of 14% from the previous close of ₹5,881.

Mukul Agrawal portfolio stock: Indo Count surges 14%, hits 52-week high

Indo Count Q4 results: EBITDA and margins witnessed recovery driven by higher contribution from new businesses due to absorption of incubation costs and favourable exchange rate.

Tilaknagar Industries share price falls 7% as company swings to loss in Q4

Tilaknagar Industries has reported a net loss of ₹14.91 crore in Q4FY27 versus a net profit of ₹77.35 crore in the same quarter a year ago.

Natco Pharma stock price slips 20% in 2 days; should you buy, sell or hold?

Natco Pharma's management expects better FY28 with traction coming from Canada, Brazil and India besides some niche launches in the US which can translate into 15- 25 per cent PAT growth.

BofA sees structural growth opportunity in Lenskart; initiates with 'Buy'

According to analysts Aditya Mathur, Pritesh Sonar and Arashi Nishizawa, Lenskart's scalable and integrated operating model-underpinned by technology-differentiates it from peers

RateGain Travel at 52-wk high, up 7%; here's why stock rose 83% since April

On the margin front, RateGain's management expects the company to deliver an EBITDA of ₹650 crore to ₹700 crore at a margin of 21.5 per cent to 22.5 per cent for FY27.

Asian Paints rises 4% after Q4; brokerages upbeat on demand, margin outlook

Asian Paints reported a 69.15 per cent Y-o-Y increase in consolidated net profit at ₹1,185.49 crore for March 2026 quarter. Its revenue grew by 10.79 per cent to ₹9,228.46 crore.